Caristo Diagnostics

Organization · Startup · UK · 1 item since Jul 2026

Deals & regulation

Jul 29
Authorized by U.S. Food and Drug Administration

Models & products

Products: CaRi-Heart

Trends

FDA authorizations extend clinical AI into new specialties and LLMs

Items

Jul 29
FDA authorizes Caristo's CaRi-Heart
A De Novo authorization makes CaRi-Heart the first US-authorized technology to quantify coronary inflammation from routine coronary CT angiography, producing a fat-attenuation-index biomarker and a 10-year cardiac-risk score.